- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00628498
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study (Treatment IND)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35233
- Children's Hospital of Alabama
-
-
Arizona
-
Phoenix, Arizona, United States, 85016
- Phoenix Children's Hospital
-
Phoenix, Arizona, United States, 85054
- Mayo Clinic Cancer Center
-
Scottsdale, Arizona, United States, 85258
- Arizona Oncology
-
Tucson, Arizona, United States, 85724
- University Medical Center
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas For Medical Services
-
-
California
-
Duarte, California, United States, 91010
- City of Hope Medical Center
-
La Jolla, California, United States, 92037
- The University of California, San Diego
-
Loma Linda, California, United States, 92354
- Loma Linda University
-
Long Beach, California, United States, 90806
- Long Beach Memorial Medical Center
-
Los Angeles, California, United States, 90027
- Children's Hospital of Los Angeles
-
Oakland, California, United States, 94609
- Children's Hospital & Research Center Oakland
-
Orange, California, United States, 92868
- Children's Hospital of Orange County (CHOC)
-
Sacramento, California, United States, 95816
- Sutter Institute for Medical Research
-
Sacramento, California, United States, 95817
- University of California Davis Health System
-
San Diego, California, United States, 92123
- Rady's Children's Hospital - San Diego
-
San Francisco, California, United States, 94143
- University of California San Francisco Medical Center
-
Stanford, California, United States, 94305
- Stanford University Medical Center
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Children's Hospital Colorado
-
Denver, Colorado, United States, 80218
- US Oncology - Denver
-
-
Connecticut
-
New Haven, Connecticut, United States, 06520
- Yale - New Haven Hospital
-
-
Delaware
-
Wilmington, Delaware, United States, 19803
- Nemours-Al duPont Hospital for Children
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
- Children's National Medical Center
-
Washington, District of Columbia, United States, 20007
- Georgetown University Hospital
-
-
Florida
-
Gainesville, Florida, United States, 32610
- UF Health Shands Hospital
-
Miami, Florida, United States, 33136
- Jackson Memorial- University of Miami Health System- Pediatrics
-
Miami, Florida, United States, 33155
- Nicklaus Children's Hospital (Miami Children's Hospital)
-
Orlando, Florida, United States, 42803
- Florida Hospital
-
Saint Petersburg, Florida, United States, 33701
- All Children's Hospital Specialty Physicians
-
Tampa, Florida, United States, 33612
- H. Lee Moffitt Cancer Center & Research Institute
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University Hospital
-
Atlanta, Georgia, United States, 30342
- Northside Hospital
-
Atlanta, Georgia, United States, 30322
- Childrens Healthcare of Atlanta
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96826
- Kapi'olani Medical Center for Women and Children
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Ann & Robert H. Lurie Children's Hospital of Chicago
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Chicago, Illinois, United States, 60611
- Northwest Memorial Hospital
-
Chicago, Illinois, United States, 60637
- Pediatric Hematology/Oncology MC4060 - University of Chicago
-
Maywood, Illinois, United States, 60153
- Cardinal Bernardin Cancer-Loyola University Medical Center
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Riley Hospital for Children
-
Indianapolis, Indiana, United States, 46237
- Indiana Blood and Marrow Transplantation Clinical Lab LLC/St. Francis Hospital
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa Hospitals & Clinics
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Cancer Center
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Pediatric Blood and Cancer Disorders Clinic
-
Louisville, Kentucky, United States, 40202
- University of Louisville Research Foundation
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70118
- Children's Hospital
-
New Orleans, Louisiana, United States, 70112
- Tulane University Hospital & Clinic (Tuhc) - Tulane Cancer Center Comprehensive Clinic (Tcccc)
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins University
-
Baltimore, Maryland, United States, 21201
- University of Maryland - Greenebaum Cancer Center
-
Bethesda, Maryland, United States, 20892
- National Institutes of Health
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, United States, 02115
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Boston, Massachusetts, United States, 02111
- Tufts Medical Center
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital DFCI/CHB-Pediatrics
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Health System
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital
-
Detroit, Michigan, United States, 48201
- Wayne State University/Children's Hospital of Michigan
-
Grand Rapids, Michigan, United States, 49503
- Helen DeVos Children's Hospital - Spectrum Health
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- University Of Minnesota Medical Center
-
Minneapolis, Minnesota, United States, 55404
- Children's Hospitals and Clinics of Minnesota and Minneapolis
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- University of Mississippi Medical Center
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospital and Clinics - Infectious Diseases
-
Saint Louis, Missouri, United States, 63110
- Washington University/St. Louis Children's Hospital
-
Saint Louis, Missouri, United States, 63104
- Cardinal Glennon Children's Medical Center/St. Louis University Department of Pediatrics
-
-
Nebraska
-
Omaha, Nebraska, United States, 68198
- University of Nebraska Medical Center
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Hackensack University Medical Center - Joseph M. Sanzari Childrens Hospital
-
New Brunswick, New Jersey, United States, 08903
- Rutgers Cancer Institute of New Jersey
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87106
- Presbyterian Hospital
-
-
New York
-
Buffalo, New York, United States, 14263
- Roswell Park Cancer Institute
-
New Hyde Park, New York, United States, 11040
- Steven and Alexandra Cohen Children's Medical Center
-
New York, New York, United States, 10016
- New York University School of Medicine
-
New York, New York, United States, 10021
- Memorial Sloan Kettering Cancer Center
-
New York, New York, United States, 10029
- Mount Sinai Medical Center
-
New York, New York, United States, 10065
- Weill Cornell Medical College - New York Presbyterian Hospital
-
New York, New York, United States, 10029
- Mount Sinai Hospital - BMT Program
-
New York, New York, United States, 10032
- Morgan Stanley Children's Hospital - Columbia University Medical Center
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center, Strong Memorial Hospital
-
Stony Brook, New York, United States, 11794
- Stony Brook University Hospital
-
The Bronx, New York, United States, 10467
- Montefiore Medical Center
-
Valhalla, New York, United States, 10595
- New York Medical College
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- The University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, United States, 28203
- Levine Children's Hospital
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Health
-
-
Ohio
-
Akron, Ohio, United States, 44308
- Children's Hospital Medical
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
Cincinnati, Ohio, United States, 45236
- The Jewish Hospital
-
Cleveland, Ohio, United States, 44106
- Case Western Reserve University (Cwru) - University Hospitals of Cleveland (Uhc)
-
Cleveland, Ohio, United States, 44195
- Robert J Tomsich Pathology & Laboratory Medicine Institute
-
Columbus, Ohio, United States, 43210
- The Ohio State University, James Cancer Hospital
-
Columbus, Ohio, United States, 43205
- Nationwide Children's Hospital - Ohio State University College of Medicine (OSUCOM)
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- The University of Oklahoma Health Science Center
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health and Science University
-
Portland, Oregon, United States, 97239
- Doernbecher Children's Hospital - Oregon Health and Science University
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Hershey, Pennsylvania, United States, 17033
- Milton S. Hershey Medical Center
-
Philadelphia, Pennsylvania, United States, 19104
- The Children's Hospital of Philadelphia
-
Pittsburgh, Pennsylvania, United States, 15219
- Children's Hospital of Pittsburgh of UPMC
-
Pittsburgh, Pennsylvania, United States, 15224
- West Penn Allegheny Health System
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
Greenville, South Carolina, United States, 29605
- Greenville Health System Cancer Institute
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Avera Cancer Institute
-
-
Tennessee
-
Memphis, Tennessee, United States, 38104
- Methodist University Hospital
-
Memphis, Tennessee, United States, 38105
- St. Jude Children's Research Hospital - Department of Bone Marrow Transplantation and Cellular Therapy
-
Nashville, Tennessee, United States, 37203
- The Children's Hospital at TriStar Centennial
-
Nashville, Tennessee, United States, 37232
- Vanderbilt Ingram Cancer Center
-
-
Texas
-
Dallas, Texas, United States, 75235
- Children's Medical Center of Dallas
-
Fort Sam Houston, Texas, United States, 78234
- San Antonio Military Medical Center
-
Fort Worth, Texas, United States, 76104
- Cook Children's Health Care Hospital
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
Houston, Texas, United States, 77030
- Texas Children's Hospital
-
Houston, Texas, United States, 77030
- The University of Texas - MD Anderson Cancer Center
-
San Antonio, Texas, United States, 78229
- Methodist Healthcare System of San Antonio
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- University of Utah
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- University of Virginia Health System
-
Norfolk, Virginia, United States, 23507
- Children's Hospital of The King's Daughter
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Washington
-
Seattle, Washington, United States, 98109
- Fred Hutchinson Cancer Research Center/Seattle Children Hospital
-
Spokane, Washington, United States, 99204
- Providence Sacred Heart Medical Center and Children's Hospital
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26505
- Mary Babb Randolph Cancer Center - West Virginia University Hospital
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin, American Family Children's Hospital, Medical School
-
Milwaukee, Wisconsin, United States, 53226
- Medical College of Wisconsin/ Children's Hospitalof Wisconsin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Entry criteria include the following:
Clinical diagnosis of VOD, made by Baltimore Criteria, Modified Seattle Criteria, or biopsy proven:
1.1 Baltimore Criteria- Bilirubin ≥2 mg/dL and at least 2 of the following clinical findings:
- Ascites (radiographic or physical exam)
- Weight gain of ≥5% compared to the day of conditioning-- if this value is not available, the weight on the date of admission to the SCT unit may be used)
- Hepatomegaly; increased over baseline.
1.2 Modified Seattle Criteria: At least two of the following
- Bilirubin ≥2 mg/dL
- Ascites (radiographic or physical exam) and/or weight gain ≥5% above baseline weight (defined as weight on the first day of conditioning- if this value is not available, the weight on the date of admission to the SCT unit may be used)
- hepatomegaly increased over baseline
1.3 Patients that do not meet the Baltimore Criteria or Modified Seattle Criteria and have biopsy proven VOD are eligible.
- Patient must also provide written informed consent.
Exclusion Criteria:
- Use of any medication which increases the risk of hemorrhage is disallowed. Use of heparin or other anticoagulants is disallowed within 12 hours unless being used for routine central venous line management, fibrinolytic instillation for central venous line occlusion, intermittent dialysis or ultrafiltration of CVVH.
- Clinically significant uncontrolled acute bleeding, defined as hemorrhage requiring > 15 cc/kg of packed red blood cells (e.g., a pediatric patient weighing 20 kg and requiring > 300cc of packed red blood cells/24 hours, or an adult patient weighing 70 kg and requiring >3 units of packed red blood cells/24 hours) to replace blood loss, OR bleeding from a site which in the Investigator's opinion constitutes a potential life-threatening source (e.g. pulmonary hemorrhage or CNS bleeding), irrespective of amount of blood loss, at any point from the date of SCT through the date of severe VOD diagnosis.
- Hemodynamic instability as defined by a requirement for multiple pressors, or inability to maintain mean arterial pressure (for children: to maintain mean arterial pressure within 1 standard deviation of age-adjusted levels) with single pressor support.
- Woman who are pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Defibrotide
Defibrotide 25 mg/kg day given in 4 divided doses approximately every 6 hours
|
Defibrotide is a single-stranded polydeoxyribonucleotide derived from porcine intestinal mucosa by controlled depolymerisation. Defibrotide has a complex mechanism of action with antithrombotic, anti-ischemic, anti-inflammatory, anti-adhesive and thrombolytic properties but no significant systemic anti-coagulant effects. Defibrotide is dose intravenously as a 2-hour infusion every 6 hours at a dose of 25 mg/kg/day. Recommended duration of therapy is 21 days. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Survival by Day+100 Post Stem Cell Transplant or Chemotherapy
Time Frame: Day +100 from HSCT or 100 days from start of chemotherapy
|
Day +100 from HSCT or 100 days from start of chemotherapy
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: William Tappe, M.D., Jazz Pharmaceuticals
- Principal Investigator: Paul Richardson, M.D., Dana-Farber Cancer Institute
Publications and helpful links
General Publications
- Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood. 2002 Dec 15;100(13):4337-43. doi: 10.1182/blood-2002-04-1216. Epub 2002 Aug 1.
- Richardson PG, Smith AR, Kernan NA, Lehmann L, Ryan RJ, Grupp SA. Analysis of Time to Complete Response after Defibrotide Initiation in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Transplant Cell Ther. 2021 Jan;27(1):88.e1-88.e6. doi: 10.1016/j.bbmt.2020.09.008. Epub 2020 Sep 17.
- Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, Lehmann L, Shore T, Ho VT, Bunin N, Iacobelli M, Liang W, Hume R, Tappe W, Soiffer R, Richardson P. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome. Br J Haematol. 2018 Jun;181(6):816-827. doi: 10.1111/bjh.15267. Epub 2018 May 16.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P2006-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hepatic Veno-Occlusive Disease
-
St. Jude Children's Research HospitalNo longer availableHepatic Veno-occlusive DiseaseUnited States
-
Jazz PharmaceuticalsFDA Office of Orphan Products DevelopmentCompletedSevere Hepatic Veno-Occlusive DiseaseUnited States, Canada
-
Jazz PharmaceuticalsCompletedVeno-occlusive DiseaseUnited States, Spain, Belgium, Australia, Italy, Israel, Japan, Korea, Republic of, France, Canada, United Kingdom, Germany, New Zealand, Turkey
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedStem Cell Transplant Complications | Sinusoidal Obstruction Syndrome | Veno Occlusive Disease, HepaticItaly
-
Emory UniversityNo longer availableDefibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the LiverLiver DiseasesUnited States
-
Children's Mercy Hospital Kansas CityChildren's Hospital Colorado; St. Jude Children's Research Hospital; Nationwide...WithdrawnStem Cell Transplant Complications | Bone Marrow Transplant Complications | Sinusoidal Obstruction Syndrome | Veno Occlusive Disease, HepaticUnited States
-
New York Medical CollegeRecruitingSinusoidal Obstruction Syndrome | Veno-occlusive DiseaseUnited States
-
Children's Mercy Hospital Kansas CityDana-Farber Cancer Institute; Duke University; University of California, San... and other collaboratorsRecruitingStem Cell Transplant Complications | Bone Marrow Transplant Complications | Sinusoidal Obstruction Syndrome | Veno Occlusive Disease, HepaticUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Jazz PharmaceuticalsCompletedVeno-occlusive DiseaseUnited States
-
Loyola UniversityRecruitingBone Marrow Transplant Complications | Sinusoidal Obstruction Syndrome | Veno-occlusive DiseaseUnited States
Clinical Trials on Defibrotide
-
IRCCS San RaffaeleCompletedPatients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failureItaly
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Jazz PharmaceuticalsCompletedVeno-occlusive DiseaseUnited States
-
Cumberland PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Loyola UniversityRecruitingBone Marrow Transplant Complications | Sinusoidal Obstruction Syndrome | Veno-occlusive DiseaseUnited States
-
New York Medical CollegeJohns Hopkins University; Baylor College of Medicine; University of California... and other collaboratorsRecruitingSickle Cell DiseaseUnited States
-
University of California, San FranciscoCompleted
-
Emory UniversityNo longer availableDefibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the LiverLiver DiseasesUnited States
-
Brigham and Women's HospitalJazz PharmaceuticalsRecruiting
-
Jazz PharmaceuticalsTerminatedNeurotoxicity Syndromes | DLBCLUnited States
-
University of California, San FranciscoJazz PharmaceuticalsNot yet recruitingThrombotic Microangiopathies | Neuroblastoma | High-risk Neuroblastoma | Transplant-Associated Thrombotic MicroangiopathyUnited States